Medicines Marketed by Axa Parenterals Ltd

About Axa Parenterals Ltd.

Axa Parenterals Ltd. is a prominent player in the pharmaceutical industry, specialising in the manufacture and marketing of sterile parenteral preparations, life-saving medicines, and hospital products. Established in 2005, the company is based in Roorkee, Uttarakhand, India, with its main manufacturing facility located there.

Axa Parenterals Ltd. has a significant global presence, exporting its products to over 61 countries, including those in Africa, the CIS countries, and Southeast Asia. The company's extensive reach and diverse product range enable it to cater to a broad customer base across multiple regions.

Axa Parenterals Ltd. Products

Axa Parenterals Ltd. is involved in the manufacturing of a wide range of sterile parenteral products using advanced technologies such as Form-Fill-Seal (FFS) technology. The company's product portfolio includes Large Volume Parenterals (LVP), Respules, preservative-free single and multiple-dose eye drops, and intravenous fluids manufactured in high-quality Medigrade Plastic LDPE granules under aseptic conditions.

Through its 100% subsidiary, Heilsa Life Sciences, Axa Parenterals Ltd. is expanding its product line to include general injectable vials, emulsions, liposomal formulations, lyophilised products, prefilled syringes, ampoules, and separate oncology injectable blocks.

Some of the popular products are Axagyl Infusion, Supercef 250 Tablet, Levomol 0.63 mg Respules 2.5 ml, Pulmofor B 200 Inhaler, Furonase Nasal Spray, Enterobec Oral Suspension, and Fusion Fresh 0.1% Eye Drop.

The company holds WHO-GMP and PIC/S accreditations, ensuring that its products meet the highest standards of quality and safety. Axa Parenterals Ltd. is continuously expanding its capabilities and seeking alliances for further growth in Europe and globally, reflecting its commitment to innovation and staying competitive in the pharmaceutical market.